Albertsons swung to a fourth-quarter loss fueled by a charge from a new opioid settlement set to resolve substantially all opioid-related claims brought against the company. The company reported a ...
The company reported a loss of $480.8 million, or 94 cents a share, compared with a profit of $171.8 million, or 29 cents a share, the year prior. The loss included a $600 million charge related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results